Vivos Therapeutics, Inc. (VVOS) Tops Q3 EPS by 88c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts VVOS Hot Sheet
Join SI Premium – FREE
Vivos Therapeutics, Inc. (NASDAQ: VVOS) reported Q3 EPS of ($1.75), $0.88 better than the analyst estimate of ($2.63). Revenue for the quarter came in at $3.3 million versus the consensus estimate of $4.69 million.
For earnings history and earnings-related data on Vivos Therapeutics, Inc. (VVOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Centrus Energy (LEU) Misses Q3 EPS by 48c ; Offers Guidance
- Host Hotels & Resorts (HST) Tops Q3 EPS by 1c; offers guidance
- Curtiss-Wright (CW) Tops Q3 EPS by 17c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
